Point72 Asia Singapore Pte. Ltd. Sells 1,631 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Point72 Asia Singapore Pte. Ltd. reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 64.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 910 shares of the company’s stock after selling 1,631 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Acadia Healthcare were worth $36,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 0.7% in the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock valued at $465,283,000 after purchasing an additional 76,490 shares in the last quarter. FMR LLC boosted its stake in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Acadia Healthcare by 18.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock valued at $126,189,000 after purchasing an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares in the last quarter. Finally, Madison Avenue Partners LP acquired a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $76,339,000.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Guggenheim assumed coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target on the stock. KeyCorp reduced their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Mizuho cut their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 14th. Bank of America cut their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Finally, Barclays cut their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Stock Down 4.1%

Shares of NASDAQ ACHC opened at $25.08 on Tuesday. The company has a market capitalization of $2.31 billion, a P/E ratio of 8.22, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 52-week low of $20.36 and a 52-week high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company’s 50 day moving average price is $26.12 and its 200-day moving average price is $35.37.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up .3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.84 EPS. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.